Animal study demonstrates that NRG1 treatment reduces apoptosis and oxidative stress in myocardial ischemia-reperfusion injury, suggesting a protective pathway.
Key Points
Recombinant NRG1 treatment significantly reduced myocardial cell apoptosis and ROS levels compared to the MIRI group, promoting heart protection.
NRG1 levels in heart tissues were significantly reduced in the MIRI group compared to control groups, indicating potential cellular damage.
A rat model for myocardial ischemia-reperfusion injury showed that NRG1 supplementation activates the ErbB4 signaling pathway affecting oxidative stress.
AG1478 administration resulted in lower NRG1 levels and reduced protective effects, emphasizing the role of NRG1/ErbB4 signaling in heart health.